Skip to main navigation
Skip to search
Skip to main content
Universitat Autònoma de Barcelona Research Portal Home
Help & FAQ
Home
Profiles
Research Units
Projects
Research output
Search by expertise, name or affiliation
Celecoxib; tolerability and gastrointestinal safety
J. Monés Xiol
Department of Medicine
Research output
:
Contribution to journal
›
Review article
›
Research
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Celecoxib; tolerability and gastrointestinal safety'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Nonsteroid Antiinflammatory Agent
100%
Therapeutic Procedure
100%
Celecoxib
83%
Lower Digestive Tract
66%
Patient
50%
Venous Ulcer
33%
Bleeding
33%
Dyspepsia
33%
Upper Digestive Tract
33%
Gastrointestinal Complication
33%
Diseases
16%
Lesion
16%
Age
16%
Low Drug Dose
16%
Cyclooxygenase 2 Inhibitor
16%
Acetylsalicylic Acid
16%
Perforation
16%
Steroid
16%
Enteropathy
16%
Antithrombotic
16%
Proton-Pump Inhibitor
16%
Helicobacter Pylori
16%
Inpatient
16%
Pharmacology, Toxicology and Pharmaceutical Science
Celecoxib
83%
Complication
50%
Bleeding
33%
Dyspepsia
33%
Ulcer
33%
Diseases
16%
Anticoagulant Agent
16%
Tolerability
16%
Proton Pump Inhibitor
16%
Steroids
16%
Helicobacter Pylori
16%
Enteropathy
16%
Gastroenterology
16%
Perforation
16%
Biochemistry, Genetics and Molecular Biology
Celecoxib
83%
Low Drug Dose
16%
Steroids
16%
Helicobacter Pylori
16%
Age
16%
Compliance (Physical)
16%
Neuroscience
Celecoxib
83%
Anticoagulant
16%
Proton Pump Inhibitor
16%
Gastroenterology
16%
Aspirin
16%
Psychology
Treatment
100%
Lesions
16%
Proton Pump
16%